Versant Venture Capital V, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Turnstone Biologics Corp., Crinetics Pharmaceuticals, Inc., Gritstone Oncology, Inc., Repare Therapeutics Inc., CRISPR Therapeutics AG, and Aprea Therapeutics, Inc..